TITLE

Review: Cardioselective β-blockers do not produce adverse respiratory effects in COPD

PUB. DATE
May 2006
SOURCE
ACP Journal Club;May/Jun2006, Vol. 144 Issue 3, p66
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses a study which determines whether cardioselective β-blockers cause adverse respiratory effects in patients with chronic obstructive pulmonary disease (COPD). 20 RCTs that evaluated cardioselective β-blockers as a single dose or for an extended period in patients with COPD and reported change in FEV or respiratory symptoms met the selection criteria of the study. Analyses showed that single-dose or longer-duration cardioselective β-blockers did not affect change in FEV in patients with severe COPD. The study found that in patients with chronic obstructive pulmonary disease, cardioselective β-blockers do not change FEV or increase respiratory symptoms.
ACCESSION #
21490783

 

Related Articles

  • COPD in the News.  // AARC Times;Sep2010, Vol. 34 Issue 9, p89 

    The article offers information related to medicine. It discusses the studies related to treatments of patients with exacerbation of chronic obstructive pulmonary disease (COPD) using beta-blocker and antibiotics. It says that plastic surgeons in New Jersey performed a phrenic nerve decompression...

  • β-blockers associated with reduced all-cause mortality in COPD. Tashkin, Donald P. // Evidence Based Medicine;Feb2012, Vol. 17 Issue 1, p31 

    The author comments on the article "Effect of Beta Blockers in Treatment of Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study," by PM Short and colleagues published in the "British Medical Journal." He argues that the limitations of the study include those that are common in...

  • β blockers in COPD.  // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;6/5/2010, Vol. 340 Issue 7758, p1227 

    An online discussion concerning a study on the use of Î’ blockers to reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary diseases (COPD) is presented.

  • Should Patients with COPD Exacerbations Receive Beta Blockers? Pierson, David J. // Critical Care Alert;Aug2008, Vol. 16 Issue 5, p37 

    The article presents the findings of a study that utilizes beta blockers on patients with chronic obstructive pulmonary disease (COPD) exacerbations.

  • Use of β blockers in patients with COPD. Au, David H. // Thorax;Apr2008, Vol. 63 Issue 4, p296 

    The article discusses a paper published within this issue about the use of β blockers in patients with chronic obstructive pulmonary disease (COPD).

  • Review: Cardioselective β-blockers do not produce adverse respiratory effects in COPD: COMMENTARY. Lacasse, Yves // ACP Journal Club;May/Jun2006, Vol. 144 Issue 3, p66 

    The article presents comments of the author on a study which found that cardioselective β-blockers do not produce adverse respiratory effects in COPD. The well-conducted meta-analysis by researchers of the study vividly illustrates one of the assumptions of the new paradigm of evidence-based...

  • Should Patients with COPD Exacerbations Receive Beta Blockers? Pierson, David J. // Internal Medicine Alert;8/15/2008, Vol. 30 Issue 15, p113 

    The findings of this retrospective study of 825 patients hospitalized with COPD exacerbations indicate that the use of beta blockers in such patients is not harmful and may actually be associated with reduced mortality.

  • 526 Use of beta blockers in HF patients with chronic obstructive pulmonary disease. Lourenco, P.; Mascarenhas, J.; Lopes, R.; Azevedo, A.; Bettencourt, P. // European Journal of Heart Failure. Supplements; 

    The article presents an abstract of the study "Use of Beta Blockers in HF Patients with Chronic Obstructive Pulmonary Disease," by P. Lourenco and colleagues.

  • Impact of coronary angioplasty. Sanfilippo, Filippo; Santonocito, Cristina; Foex, Pierre; Quint, Jennifer K. // BMJ: British Medical Journal;2/1/2014, Vol. 348 Issue 7943, p23 

    A response from the author of the article "Effect of ß Blockers on Mortality After Myocardial Infarction in Adults With COPD: Population Based Cohort Study of UK Electronic Health care Records" in the November 22, 2013 issue, is presented.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics